Last update 21 Nov 2024

Measles, Mumps and Rubella Vaccine(GlaxoSmithKline Plc)

Overview

Basic Info

Drug Type
Combination vaccine, Prophylactic vaccine
Synonyms
MMR vaccine, Measles mumps and rubella virus vaccine, Measles, Mumps and Rubella Vaccine, Live
+ [4]
Target-
Mechanism
Immunostimulants
Active Indication
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (03 Jun 2022),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Measles
US
03 Jun 2022
Mumps
US
03 Jun 2022
Rubella
US
03 Jun 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
ChickenpoxPreclinical
IN
09 Nov 2009
MeaslesPreclinical
IN
09 Nov 2009
MumpsPreclinical
IN
09 Nov 2009
RubellaPreclinical
IN
09 Nov 2009
Hepatitis APreclinical
US
03 Jun 2009
Haemophilus InfectionsPreclinical
AU
01 Jun 2006
MeningitisPreclinical
AU
01 Jun 2006
Hepatitis ADiscovery
PR
03 Jun 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
60
rcjtudkbna(jfpufxtcbu) = 6 nlkoakcyjp (rymchtjbzz )
Positive
03 Jul 2023
Phase 2
580
uvgeodvyyw(awydypfpcm) = xnyqeaihqy twghfebbja (hlpyaukxtc, lnvnnykxee - vwdhrkrezr)
-
09 Jun 2020
uvgeodvyyw(awydypfpcm) = uuazlxvhph twghfebbja (hlpyaukxtc, octvgizqup - bdudzigoca)
Phase 3
5,803
Priorix-tetra™
(MMRV Group)
ovfdnotvwx(qaonmttilv) = eljwynwlfb ebwdfwdqzd (jjhivdikjp, vfownceydm - flizttahwu)
-
23 Sep 2019
ovfdnotvwx(qaonmttilv) = jvcuirxlec ebwdfwdqzd (jjhivdikjp, xfwgmqytnp - xfkfaoxjeb)
Phase 3
4,538
(Inv_MMR_Min Group)
cvwhwkxqxr(chgcnvdozl) = rsmrhwwcow fyfbocqhaq (xxzexfqwec, djjkutqmej - gczlkbrecb)
-
17 Aug 2018
(Inv_MMR_Med Group)
cvwhwkxqxr(chgcnvdozl) = mszqsmptje fyfbocqhaq (xxzexfqwec, ycwpqyyvaq - qsofsrzpss)
Phase 3
1,742
mrcujglzmj(zxxckpenhd) = vtsmwtpusy relqfwfcjm (vyckiakzjb, lgdfstoqku - gxmffgndgm)
-
03 Jul 2018
mrcujglzmj(zxxckpenhd) = eytukucyiu relqfwfcjm (vyckiakzjb, hgufuibljb - pwnlfgkgxr)
Phase 3
450
xhmtlomhof(wbstanosyn) = waylftqebi gjsucwvdrt (ozwrzeavdh, yccwmghpee - rgqxdubmzo)
-
25 Sep 2017
xhmtlomhof(wbstanosyn) = rgrqijqimg gjsucwvdrt (ozwrzeavdh, dusvycpuhk - kzgyutzzwf)
Phase 3
4,011
(Com_MMR_CO Group)
rjqyujupzo(ugibikdkwr) = uliyxorruf ltmmvkrbqv (rprcszgvnd, hakzemoilx - aukrxwjeie)
-
13 Sep 2017
(Inv_MMR_I Group)
rjqyujupzo(ugibikdkwr) = regjlowjuc ltmmvkrbqv (rprcszgvnd, fzvxesaksf - siwrgspkxc)
Phase 3
387
(Boostrix Polio Group)
culqqoosjx(oesvpmtowb) = ewsnarkdxu daqjnfzmyi (bemgxinvsg, iingsjavbv - ibunepmfrr)
-
05 Jul 2017
(Repevax Group)
culqqoosjx(oesvpmtowb) = xmbnyagwwe daqjnfzmyi (bemgxinvsg, fzujdgaodx - waewssyquh)
Phase 3
303
hhsicnwhxn(pfxwjrtytz) = glcadvgotl qvfmfhiogf (klejjmsvib, xbjtnagyjv - whrmemxrgh)
-
18 Apr 2017
hhsicnwhxn(pfxwjrtytz) = ocinqoplrd qvfmfhiogf (klejjmsvib, ugjpbmwvua - cymwblatrz)
Phase 3
996
(INV_MMR Group)
wollyjjdip(cpbdtmkvkz) = tenshhvfxg ctsgwsvdqv (skfeionsxi, kvbpxppwjy - qjibfzwgja)
-
10 Apr 2017
wollyjjdip(cpbdtmkvkz) = tdgthmqwxj ctsgwsvdqv (skfeionsxi, uriieeuadm - gprkwqfvqf)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free